Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

CGEM

Cullinan Therapeutics Inc

Apr 24 • 10:12AM ET

17.80

Dollar change +1.13
Percentage change 6.78	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN IBB SCHA DFAT VTWO FDM DFAC

Index	RUT	P/E	-	EPS (ttm)	-3.70	Insider Own	38.80%	Shs Outstand	42.90M	Perf Week	-0.45%
Market Cap	766.65M	Forward P/E	-	EPS next Y	-3.03	Insider Trans	-0.80%	Shs Float	26.36M	Perf Month	5.14%
Income	-153.16M	PEG	-	EPS next Q	-0.97	Inst Own	56.14%	Short Float	5.45%	Perf Quarter	42.40%
Sales	0.00M	P/S	-	EPS this Y	11.25%	Inst Trans	-1.51%	Short Ratio	2.70	Perf Half Y	111.65%
Book/sh	10.58	P/B	1.68	EPS next Y	7.37%	ROA	-29.28%	Short Interest	1.44M	Perf Year	66.67%
Cash/sh	10.84	P/C	1.64	EPS next 5Y	-	ROE	-30.98%	52W Range	7.64 - 20.62	Perf YTD	74.68%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-62.42%	ROI	-33.60%	52W High	-13.68%	Beta	0.32
Dividend TTM	-	Quick Ratio	17.07	Sales past 5Y	-20.00%	Gross Margin	-	52W Low	132.98%	ATR (14)	1.37
Dividend Ex-Date	-	Current Ratio	17.07	EPS Y/Y TTM	-248.40%	Oper. Margin	0.00%	RSI (14)	55.92	Volatility	11.33% 7.63%
Employees	85	Debt/Eq	0.01	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	28.00
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	4.99%	Payout	-	Rel Volume	0.74	Prev Close	16.67
Sales Surprise	-	EPS Surprise	43.83%	Sales Q/Q	-	Earnings	Mar 14 BMO	Avg Volume	531.37K	Price	17.80
SMA20	4.71%	SMA50	3.67%	SMA200	48.14%	Trades		Volume	59,510	Change	6.78%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-15-24	Initiated	William Blair	Outperform
Feb-15-24	Initiated	Wedbush	Outperform	$30
Jun-15-23	Initiated	TD Cowen	Outperform
Nov-21-22	Initiated	BTIG Research	Buy	$20
Apr-27-21	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$40
Feb-02-21	Initiated	SVB Leerink	Outperform	$52
Feb-02-21	Initiated	Morgan Stanley	Equal-Weight	$38
Feb-02-21	Initiated	Evercore ISI	Outperform	$55
Feb-01-21	Initiated	H.C. Wainwright	Buy	$47

Today 10:09AM	Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024 (GlobeNewswire) +6.78%
Apr-16-24 03:32PM	Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity (Benzinga)
07:00AM	Cullinan Therapeutics Announces Strategic Expansion into Autoimmune Diseases (GlobeNewswire)
06:59AM	Cullinan Therapeutics Announces Oversubscribed $280 million Private Placement (GlobeNewswire)
04:48AM	Cullinan changes name, pivots to autoimmune disease (BioPharma Dive)
05:31AM	Loading…
Mar-16-24 05:31AM	Cullinan Oncology Inc (CGEM) Reports Fourth Quarter and Full Year 2023 Financial Results (GuruFocus.com)
Mar-14-24 12:53PM	CGEM Stock Earnings: Cullinan Oncology Beats EPS for Q4 2023 (InvestorPlace)
07:00AM	Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-01-24 07:00AM	Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma (GlobeNewswire)
Feb-27-24 08:00AM	Cullinan Oncology to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-21-24 09:21AM	13 Best Booming Stocks to Buy Right Now (Insider Monkey)
Feb-02-24 11:01PM	Chief Business Officer Corrine Savill Sells 40,000 Shares of Cullinan Oncology Inc (GuruFocus.com)
Jan-30-24 11:01PM	Chief Business Officer Corrine Savill Sells 40,000 Shares of Cullinan Oncology Inc (GuruFocus.com)
Jan-24-24 07:02PM	Insider Sell: Cullinan Oncology Inc's Chief Business Officer Corrine Savill Sold 40,000 Shares (GuruFocus.com)
Dec-18-23 04:53PM	Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +10.80%
04:30PM	Loading…
Dec-14-23 04:30PM	Cullinan Oncology Announces First Patient Dosed in Phase 1 Trial Evaluating CLN-617, a Novel Fusion Protein Uniquely Harnessing Both IL-2 and IL-12 Cytokines (GlobeNewswire)
Nov-08-23 07:00AM	Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-03-23 12:01PM	Cullinan Oncology to Present Data Demonstrating Progress Across Its Broad Immunotherapy-Pipeline at SITC 2023 (GlobeNewswire) +5.53%
Oct-30-23 08:00AM	Cullinan Oncology to Participate in Upcoming Investor Conferences (GlobeNewswire)
Sep-06-23 08:00AM	Cullinan Oncology to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-10-23 07:00AM	Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-09-23 07:00AM	Cullinan Oncology Announces First Patient Dosed in Phase 1 Trial Evaluating CLN-978, a Novel CD19xCD3 T cell Engager, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (GlobeNewswire)
Aug-03-23 04:15PM	REZILIENT3 Global First-Line Trial of Zipalertinib Launched in Patients With Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations (PR Newswire)
Jul-31-23 08:00AM	Cullinan Oncology to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jun-09-23 04:07PM	Why Shares of Cullinan Oncology Jumped This Week (Motley Fool)
May-25-23 05:00PM	Cullinan Oncology to Present First Monotherapy Clinical Data for CLN-619, a Novel Anti-MICA/B Antibody, at ASCO 2023 (GlobeNewswire)
May-11-23 04:01PM	Cullinan Oncology Provides Corporate Update and Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-26-23 10:08AM	Cullinan Oncology to Present First Clinical Data Evaluating Novel Anti-MICA/B Antibody, CLN-619, in Patients with Advanced Solid Tumors at ASCO 2023 (GlobeNewswire)
Apr-20-23 07:00AM	Cullinan Oncology to Participate in Stifels 2023 Targeted Oncology Days (GlobeNewswire)
Mar-29-23 10:13AM	12 Cheap Healthcare Stocks to Buy in 2023 (Insider Monkey)
07:00AM	Loading…
Mar-27-23 07:00AM	Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-617, a Novel Fusion Protein Harnessing IL-2 and IL-12 Cytokines (GlobeNewswire)
Mar-14-23 04:35PM	Cullinan Oncology to Present New Preclinical Data for CLN-619 and CLN-617 at the 2023 American Association for Cancer Research Annual Meeting (GlobeNewswire)
Mar-09-23 07:00AM	Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Feb-27-23 08:00AM	Cullinan Oncology to Participate in Cowens 43rd Annual Health Care Conference (GlobeNewswire)
Feb-13-23 07:00PM	Cullinan Oncology Licenses U.S. Rights to the First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator from Harbour BioMed (GlobeNewswire)
Feb-02-23 04:01PM	Cullinan Oncology to Participate in the Guggenheim 5th Annual Oncology Conference and the SVB Securities Global Biopharma Conference (GlobeNewswire)
Feb-01-23 04:42PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-24-23 08:00AM	Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-978, a Novel T-Cell Engager for the Treatment of Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (GlobeNewswire) +5.53%
Jan-23-23 11:07AM	12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds (Insider Monkey)
Jan-03-23 05:13PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-28-22 10:31PM	11 Cheap Value Stocks to Buy According to Seth Klarman (Insider Monkey)
Dec-02-22 05:00PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-14-22 07:00AM	Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-02-22 08:00AM	Cullinan Oncology Announces the Appointment of David P. Ryan, M.D. to its Board of Directors (GlobeNewswire)
Nov-01-22 05:23PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:00AM	Cullinan Oncology to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-25-22 07:00AM	Cullinan Oncology Significantly Increases Ownership Stake in its MICA Subsidiary which Holds Worldwide Rights to Clinical-Stage Novel Monoclonal Antibody CLN-619 (GlobeNewswire) +6.03%
Oct-03-22 04:50PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-07-22 08:00AM	Cullinan Oncology to Participate in the HC Wainwright Global Investment Conference and the Morgan Stanley Healthcare Conference (GlobeNewswire) +5.36%
Sep-01-22 05:27PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-15-22 04:57PM	Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer (GlobeNewswire)
Aug-10-22 07:00AM	Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-01-22 04:55PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:00AM	Cullinan Oncology to Participate in BTIG Biotechnology Conference and Canaccord Growth Conference (GlobeNewswire)
Jul-29-22 05:00AM	Why are Massachusetts CEOs paid so much money? Here's a primer (American City Business Journals)
05:00AM	Best bang for the buck: Which CEOs are a bargain for shareholders? (American City Business Journals)
Jul-05-22 04:01PM	Cullinan Oncology to Participate in William Blair Biotech Focus Conference (GlobeNewswire)
Jul-01-22 04:37PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-23-22 08:00AM	Cullinan Oncology and Taiho Pharmaceutical Complete Agreement for Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417 (GlobeNewswire)
Jun-01-22 05:00PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +6.08%
May-31-22 08:00AM	Cullinan Oncology to Present Updated Data Demonstrating the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2022 ASCO Annual Meeting (GlobeNewswire) -6.88%
May-26-22 08:45AM	Cullinan Oncology to Host Analyst and Investor Briefing at 2022 ASCO Annual Meeting (GlobeNewswire)
May-19-22 08:00AM	Cullinan Oncology to Present at H.C. Wainwright Global Investment Conference (GlobeNewswire) -5.01%
May-16-22 06:45AM	Cullinan Oncology Provides Corporate Update and Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-12-22 11:18AM	Why Are Cullinan Oncology Shares Rising Today? (Benzinga) +23.12%
02:00AM	Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417 and Taihos Acquisition of Cullinan Pearl (GlobeNewswire)
May-08-22 09:23AM	Companies Like Cullinan Oncology (NASDAQ:CGEM) Are In A Position To Invest In Growth (Simply Wall St.)
May-02-22 05:00PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +7.34%
Apr-27-22 10:00AM	Cullinan Oncology to Present Updated Data Highlighting the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2022 ASCO Annual Meeting (GlobeNewswire)
Apr-05-22 08:00AM	Cullinan Oncology to Participate in Upcoming Virtual Healthcare Conferences (GlobeNewswire)
Apr-04-22 04:34PM	Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +9.55%
Mar-29-22 07:54AM	Cullinan Oncology Lead Cancer Program Shows Confirmed ORR Of 41% In Lung Cancer Setting (Benzinga)
Mar-28-22 04:01PM	Cullinan Oncology Announces Clinical and Regulatory Update for CLN-081 in NSCLC EGFR Exon 20 Patients (GlobeNewswire)
Mar-17-22 07:08AM	Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
07:00AM	Cullinan Oncology to Host CLN-081 Regulatory Update Webinar on March 28, 2022 (GlobeNewswire)
Mar-09-22 08:00AM	Cullinan Oncology to Present at the Barclays Global Healthcare Conference (GlobeNewswire) +8.91%
Mar-08-22 05:30PM	Cullinan Oncology to Present Data Demonstrating Breadth and Progress of Its Immuno-Oncology Portfolio at AACR 2022 (GlobeNewswire)
Feb-28-22 08:00AM	Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones, M.D., MPH, MBA to Chief Medical Officer and Anne-Marie Martin Ph.D. to Board of Directors (GlobeNewswire)
Feb-12-22 06:50AM	Investors in Cullinan Oncology (NASDAQ:CGEM) have unfortunately lost 66% over the last year (Simply Wall St.)
Feb-07-22 06:30AM	Cullinan Oncology to Present at SVB Leerinks 11th Annual Global Healthcare Conference (GlobeNewswire) +6.52%
Jan-10-22 06:30AM	Cullinan Oncology Forms Strategic Collaboration Agreement with Mount Sinai to Advance Oral HPK1 Protein Degrader for Cancer Treatment (GlobeNewswire)
Jan-05-22 09:00AM	Cullinan Oncology to Present at Upcoming Virtual Investor Conferences (GlobeNewswire) -6.69%
Jan-04-22 07:34AM	Cullinan Oncology stock shoots higher after lung cancer treatment granted BTD by FDA (MarketWatch)
07:00AM	FDA Grants Breakthrough Therapy Designation for Cullinan Oncologys CLN-081 in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (GlobeNewswire)
Dec-16-21 01:04PM	Cullinan Oncology Posts Updated Data for CLN-081 in NSCLC EGFR Exon 20 Patients (Benzinga)
06:30AM	Cullinan Oncology Announces Updated Phase 1/2a Data for CLN-081 in NSCLC EGFR Exon 20 Patients (GlobeNewswire)
Dec-13-21 07:00AM	Cullinan Oncology to Provide Clinical Update for CLN-081 in NSCLC EGFR Exon 20 Patients (GlobeNewswire)
Nov-22-21 12:37PM	Cullinan Oncology to Participate in the Evercore ISI 4th Annual HealthconX Conference (GlobeNewswire)
Nov-14-21 07:04AM	Cullinan Oncology, Inc. (NASDAQ:CGEM) insiders snagged a deal: Up US$35k on a US$4.3m investment (Simply Wall St.)
Nov-09-21 06:45AM	Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2021 Financial Results (GlobeNewswire)
Oct-29-21 11:47AM	Do Hedge Funds Love Cullinan Oncology, Inc. (CGEM)? (Insider Monkey)
Oct-18-21 07:00AM	Cullinan Oncology Appoints Nadim Ahmed as Chief Executive Officer (GlobeNewswire) -15.52%
Sep-08-21 04:01PM	Cullinan Oncology to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-16-21 06:44AM	We're Hopeful That Cullinan Oncology (NASDAQ:CGEM) Will Use Its Cash Wisely (Simply Wall St.)
Aug-10-21 06:30AM	Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2021 Financial Results (GlobeNewswire) +6.70%
Aug-05-21 04:05PM	Cullinan Oncology to Participate in the 41st Annual Canaccord Genuity Growth Conference (GlobeNewswire) +13.58%
Jul-19-21 07:56PM	Is Cullinan Oncology, Inc. (CGEM) A Good Stock To Buy? (Insider Monkey)
Jun-29-21 08:00AM	Cullinan Oncology Receives FDA Clearance of Investigational New Drug (IND) Application for CLN-619, a Novel MICA/B-targeted Antibody for the Treatment of Solid Tumors (GlobeNewswire)
Jun-07-21 10:57AM	Cullinan Gets FDA Investigational Clearance for Leukemia Drug (TheStreet.com)
09:26AM	Cullinan (CGEM) Rises on Promising Phase I Cancer Study Data (Zacks)

Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Savill Corrine	Chief Business Officer	Feb 01 '24	Option Exercise	4.30	40,000	172,000	205,990	Feb 02 09:35 PM
Savill Corrine	Chief Business Officer	Feb 01 '24	Sale	16.18	40,000	647,200	165,990	Feb 02 09:35 PM
Savill Corrine	Chief Business Officer	Jan 29 '24	Option Exercise	4.30	40,000	172,000	205,990	Jan 30 07:00 PM
Savill Corrine	Chief Business Officer	Jan 29 '24	Sale	14.09	40,000	563,600	165,990	Jan 30 07:00 PM
Savill Corrine	Chief Business Officer	Jan 23 '24	Option Exercise	4.30	21,316	91,659	187,306	Jan 24 05:00 PM
Savill Corrine	Chief Business Officer	Jan 23 '24	Sale	12.46	21,316	265,597	165,990	Jan 24 05:00 PM
Savill Corrine	Chief Business Officer	Jan 22 '24	Option Exercise	4.30	14,559	62,604	184,674	Jan 24 05:00 PM
Savill Corrine	Chief Business Officer	Jan 22 '24	Sale	12.14	18,684	226,911	165,990	Jan 24 05:00 PM
AHMED NADIM	President and CEO	Dec 26 '23	Sale	9.24	4,272	39,473	111,550	Dec 27 06:30 PM
Trigilio Jeffrey	Chief Financial Officer	Dec 21 '23	Sale	8.50	1,920	16,320	83,919	Dec 22 05:30 PM
Jones Jeffrey Alan	Chief Medical Officer	Dec 21 '23	Sale	8.50	1,860	15,810	56,191	Dec 22 05:30 PM
SUMER JACQUELYN L	Chief Legal Officer	Dec 21 '23	Sale	8.50	1,400	11,900	44,133	Dec 22 05:30 PM
Michaelson Jennifer	Chief Scientific Officer	Dec 21 '23	Sale	8.50	1,145	9,732	87,582	Dec 22 05:30 PM
Trigilio Jeffrey	Chief Financial Officer	Dec 18 '23	Sale	8.22	398	3,272	85,839	Dec 20 06:00 PM
Jones Jeffrey Alan	Chief Medical Officer	Dec 18 '23	Sale	8.22	386	3,173	58,051	Dec 20 06:00 PM
SUMER JACQUELYN L	Chief Legal Officer	Dec 18 '23	Sale	8.22	290	2,384	45,533	Dec 20 06:00 PM
Michaelson Jennifer	Chief Scientific Officer	Dec 18 '23	Sale	8.22	238	1,956	88,727	Dec 20 06:00 PM
Trigilio Jeffrey	Chief Financial Officer	Dec 12 '23	Sale	7.81	1,926	15,042	86,237	Dec 13 08:00 PM
Michaelson Jennifer	Chief Scientific Officer	Dec 12 '23	Sale	7.81	1,068	8,341	88,965	Dec 13 08:00 PM
AHMED NADIM	President and CEO	Jun 28 '23	Sale	11.40	759	8,653	115,822	Jun 29 04:59 PM
Trigilio Jeffrey	Chief Financial Officer	Jun 20 '23	Sale	12.94	399	5,163	85,823	Jun 21 04:17 PM
Jones Jeffrey Alan	Chief Medical Officer	Jun 20 '23	Sale	12.94	387	5,008	58,437	Jun 21 04:17 PM
SUMER JACQUELYN L	Chief Legal Officer	Jun 20 '23	Sale	12.94	291	3,766	45,823	Jun 21 04:17 PM
Michaelson Jennifer	Chief Development Officer	Jun 20 '23	Sale	12.94	238	3,080	90,033	Jun 21 04:17 PM
Trigilio Jeffrey	Chief Financial Officer	Jun 12 '23	Sale	13.11	319	4,182	86,222	Jun 14 04:35 PM
Michaelson Jennifer	Chief Development Officer	Jun 12 '23	Sale	13.11	176	2,307	90,271	Jun 14 04:35 PM
Michaelson Jennifer	Chief Development Officer	Jun 07 '23	Option Exercise	4.30	100	430	90,547	Jun 08 05:10 PM
Michaelson Jennifer	Chief Development Officer	Jun 07 '23	Sale	12.40	100	1,240	90,447	Jun 08 05:10 PM
Michaelson Jennifer	Chief Development Officer	Jun 06 '23	Option Exercise	4.30	11,900	51,170	102,347	Jun 08 05:10 PM
Michaelson Jennifer	Chief Development Officer	Jun 06 '23	Sale	12.31	11,900	146,489	90,447	Jun 08 05:10 PM
AHMED NADIM	President and CEO	May 23 '23	Sale	9.15	707	6,469	116,581	May 24 04:36 PM
Trigilio Jeffrey	Chief Financial Officer	May 18 '23	Sale	8.76	399	3,495	86,541	May 19 04:44 PM
Jones Jeffrey Alan	Chief Medical Officer	May 18 '23	Sale	8.76	394	3,451	58,824	May 19 04:46 PM
SUMER JACQUELYN L	Chief Legal Officer	May 18 '23	Sale	8.76	291	2,549	46,114	May 19 04:45 PM
Michaelson Jennifer	Chief Development Officer	May 18 '23	Sale	8.76	239	2,094	90,447	May 19 04:51 PM
Trigilio Jeffrey	Chief Financial Officer	May 12 '23	Sale	8.78	347	3,047	86,940	May 16 05:28 PM
Michaelson Jennifer	Chief Development Officer	May 12 '23	Sale	8.78	193	1,695	90,686	May 16 05:36 PM
AHMED NADIM	President and CEO	Apr 25 '23	Sale	10.59	716	7,582	117,288	Apr 26 04:23 PM

Open in Screener

RDUS

Radius Recycling Inc.

Apr 24 • 10:11AM ET

17.61

Dollar change -0.03
Percentage change -0.17	%

Basic Materials • Steel • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

RDUS Radius Recycling Inc. daily Stock Chart

Held by: VTI VB IWM VBR AVUV VXF FNDA IWN DFAT SCHA

Index	RUT	P/E	-	EPS (ttm)	-2.28	Insider Own	8.63%	Shs Outstand	27.31M	Perf Week	-3.35%
Market Cap	492.71M	Forward P/E	20.48	EPS next Y	0.86	Insider Trans	-0.84%	Shs Float	25.57M	Perf Month	-7.71%
Income	-64.30M	PEG	-	EPS next Q	-0.45	Inst Own	81.13%	Short Float	1.81%	Perf Quarter	-31.80%
Sales	2.82B	P/S	0.17	EPS this Y	-332.94%	Inst Trans	-4.02%	Short Ratio	1.98	Perf Half Y	-25.19%
Book/sh	30.18	P/B	0.58	EPS next Y	143.43%	ROA	-3.63%	Short Interest	0.46M	Perf Year	-42.28%
Cash/sh	0.48	P/C	36.34	EPS next 5Y	10.00%	ROE	-7.23%	52W Range	16.90 - 36.64	Perf YTD	-41.61%
Dividend Est.	0.75 (4.26%)	P/FCF	-	EPS past 5Y	-	ROI	-4.91%	52W High	-51.94%	Beta	1.64
Dividend TTM	0.75 (4.26%)	Quick Ratio	0.92	Sales past 5Y	8.12%	Gross Margin	9.41%	52W Low	4.20%	ATR (14)	0.96
Dividend Ex-Date	Apr 19, 2024	Current Ratio	1.96	EPS Y/Y TTM	-189.47%	Oper. Margin	0.43%	RSI (14)	38.71	Volatility	4.33% 5.45%
Employees	3353	Debt/Eq	0.58	Sales Y/Y TTM	-13.43%	Profit Margin	-2.28%	Recom	4.00	Target Price	17.00
Option/Short	Yes / Yes	LT Debt/Eq	0.55	EPS Q/Q	-885.14%	Payout	-	Rel Volume	0.71	Prev Close	17.64
Sales Surprise	-0.84%	EPS Surprise	5.02%	Sales Q/Q	-17.84%	Earnings	Apr 04 BMO	Avg Volume	234.26K	Price	17.61
SMA20	-8.10%	SMA50	-13.46%	SMA200	-32.91%	Trades		Volume	25,057	Change	-0.17%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-28-24	Downgrade	Seaport Research Partners	Neutral → Sell	$17.50
Dec-14-23	Initiated	Seaport Research Partners	Neutral
May-19-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-24-22	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$58
Jul-19-21	Initiated	Northland Capital	Outperform	$80
Apr-09-21	Initiated	Goldman	Buy	$48
Jan-12-21	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Nov-20-20	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$28
Oct-10-19	Reiterated	Cowen	Market Perform	$22 → $21
Sep-23-19	Downgrade	Goldman	Neutral → Sell	$27 → $23
Jun-25-19	Reiterated	Cowen	Market Perform	$24 → $25
Jan-14-19	Downgrade	Goldman	Buy → Neutral
Jan-09-19	Initiated	Cowen	Market Perform	$24
Aug-15-18	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Mar-20-18	Initiated	Goldman	Buy	$42
Sep-07-17	Initiated	Macquarie	Neutral
Apr-01-16	Reiterated	DA Davidson	Neutral	$15 → $18
Nov-24-15	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Jul-01-15	Upgrade	BofA/Merrill	Underperform → Buy
Jan-05-15	Downgrade	DA Davidson	Buy → Neutral	$34 → $25

Show Previous Ratings

Apr-16-24 09:00AM	Radius Announces Presentation of Data on TYMLOS (abaloparatide) at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ACCESSWIRE)
Apr-08-24 09:10AM	Radius Health, Inc. (NASDAQ:RDUS) Q2 2024 Earnings Call Transcript (Insider Monkey)
Apr-05-24 05:48PM	Radius Recycling Inc (RDUS) Q2 2024 Earnings Call Transcript Highlights: Strategic Adjustments ... (GuruFocus.com)
Apr-04-24 09:31AM	Radius Recycling Inc (RDUS) Misses Earnings Predictions with Q2 Fiscal 2024 Results (GuruFocus.com)
08:00AM	Radius Recycling Reports Second Quarter Fiscal 2024 Financial Results (GlobeNewswire)
10:58AM	Loading…
Mar-18-24 10:58AM	15 Biggest Steel Companies in the US (Insider Monkey) -7.86%
Mar-14-24 04:35PM	Second Quarter Fiscal 2024 Preliminary Results and Announcement of Earnings Date (GlobeNewswire)
Mar-09-24 07:48AM	5 Best Steel Stocks to Buy According to Analysts (Insider Monkey)
Mar-04-24 08:30AM	Radius Recycling Named One of the 2024 Worlds Most Ethical Companies (Business Wire) -5.00%
Jan-06-24 08:07AM	Radius Health, Inc. (NASDAQ:RDUS) Q1 2024 Earnings Call Transcript (Insider Monkey)
Jan-05-24 01:20AM	Q1 2024 Schnitzer Steel Industries Inc Earnings Call (Thomson Reuters StreetEvents)
Jan-04-24 03:06PM	Schnitzer Steel Industries Inc (RDUS) Faces Market Headwinds in Q1 Fiscal 2024 (GuruFocus.com) -7.69%
08:17AM	Schnitzer Steel: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
08:00AM	Radius Recycling Reports First Quarter Fiscal 2024 Financial Results (Business Wire)
Dec-18-23 09:00AM	Radius Recycling Announces First Quarter Fiscal 2024 Earnings Date and Webcast Details (Business Wire)
09:15AM	Loading…
Dec-13-23 09:15AM	Radius Recycling Publishes Fiscal Year 2023 Sustainability Report (Business Wire)
Nov-16-23 08:30AM	Radius Recycling Executive Included on TIME100 Climate List of the 100 Most Influential Leaders Driving Business Climate Action (Business Wire)
Oct-26-23 10:01AM	Radius Health, Inc. (NASDAQ:RDUS) Q4 2023 Earnings Call Transcript (Insider Monkey)
01:25AM	Q4 2023 Schnitzer Steel Industries Inc Earnings Call (Thomson Reuters StreetEvents)
Oct-25-23 09:43AM	Schnitzer Steel Industries Inc (RDUS) Reports Q4 and Fiscal 2023 Financial Results (GuruFocus.com)
08:26AM	Schnitzer Steel: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
08:00AM	Radius Recycling Reports Fourth Quarter and Fiscal 2023 Financial Results (Business Wire)
Sep-29-23 08:30AM	Radius Recycling Announces Fourth Quarter and Fiscal 2023 Earnings Date and Webcast Details (Business Wire)
Aug-30-23 08:00AM	Radius Recycling Announces Ticker Symbol Change (Business Wire)
Aug-10-23 05:31PM	Exclusive: A public company CEO on spending millions in Portland, making a risky name change (American City Business Journals)
Jul-26-23 05:45PM	Schnitzer Steel, after 117 years, renames itself (American City Business Journals)
04:00PM	Schnitzer Steel Rebrands as Radius Recycling to Reflect Companys Vision, Purpose, and Impact on Circular Economy (Business Wire)
Jul-04-23 07:33AM	Schnitzer Steel (SCHN) Q3 Earnings & Revenues Miss Estimates (Zacks)
Jun-30-23 12:48PM	Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Q3 2023 Earnings Call Transcript (Insider Monkey)
06:12AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Paying Out A Dividend Of $0.1875 (Simply Wall St.)
07:29AM	Loading…
Jun-29-23 07:29AM	Steel Stock Worthington Signals Breakout On Earnings Beat, Upbeat Outlook (Investor's Business Daily)
Jun-28-23 04:43PM	Steel Stock Worthington Jumps Near Buy Point As Earnings Beat; SCHN Falls (Investor's Business Daily)
04:13PM	Steel Stock Worthington Tests Buy Point With Earnings Due; SCHN Falls (Investor's Business Daily)
03:30PM	Steel Stock Worthington Tops Buy Point With Earnings Due; SCHN Falls (Investor's Business Daily)
02:18AM	Q3 2023 Schnitzer Steel Industries Inc Earnings Call (Thomson Reuters StreetEvents)
Jun-27-23 04:09PM	Steel Stock SCHN Falls On Mixed Quarterly Financials As Profits Drop 74% (Investor's Business Daily)
08:13AM	Schnitzer Steel: Fiscal Q3 Earnings Snapshot (AP Finance)
08:00AM	Schnitzer Reports Third Quarter Fiscal 2023 Financial Results (Business Wire)
Jun-26-23 04:07PM	Steel Stocks Flirt With Buy Points Ahead Of Earnings As Weak Demand In China Stunts Pricing (Investor's Business Daily)
Jun-23-23 06:46PM	Stock Market Action Plan: Nike, Micron, Carnival Earnings And The Bud Light Beer Wars (Investor's Business Daily)
03:01PM	Nike Faces Inventory Questions Ahead Of Earnings Report; Schnitzer Steel Offers Options Trade Idea (Investor's Business Daily)
Jun-21-23 08:45AM	Schnitzer Steel Named to TIME's List of 100 Most Influential Companies (Business Wire)
Jun-18-23 10:02AM	Schnitzer Steel Industries, Inc.'s (NASDAQ:SCHN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? (Simply Wall St.)
Jun-12-23 08:30AM	Schnitzer Announces Third Quarter Fiscal 2023 Earnings Date and Conference Call Webcast Details (Business Wire)
Jun-03-23 09:01AM	Investing in Schnitzer Steel Industries (NASDAQ:SCHN) three years ago would have delivered you a 84% gain (Simply Wall St.)
May-19-23 09:20AM	With 84% ownership, Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) boasts of strong institutional backing (Simply Wall St.)
May-05-23 08:41AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Reinvesting At Lower Rates Of Return (Simply Wall St.)
Apr-14-23 09:30AM	Schnitzer Steel (SCHN) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Apr-10-23 08:45AM	Schnitzer Steel (SCHN) Earnings and Revenues Down Y/Y in Q2 (Zacks)
Apr-08-23 08:20AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Due To Pay A Dividend Of $0.1875 (Simply Wall St.)
Apr-07-23 12:22AM	Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Apr-05-23 08:21AM	Schnitzer Steel: Fiscal Q2 Earnings Snapshot (AP Finance) -5.37%
08:00AM	Schnitzer Reports Second Quarter Fiscal 2023 Financial Results (Business Wire)
Mar-28-23 09:40AM	Should Value Investors Buy Schnitzer Steel Industries (SCHN) Stock? (Zacks)
Mar-20-23 06:00PM	Schnitzer Steel (SCHN) Outpaces Stock Market Gains: What You Should Know (Zacks)
05:00PM	Schnitzer Announces Second Quarter Fiscal 2023 Earnings Date (Business Wire)
Mar-16-23 08:34AM	Estimating The Intrinsic Value Of Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) (Simply Wall St.)
Mar-13-23 07:00AM	Schnitzer Named One of the 2023 Worlds Most Ethical Companies (Business Wire)
Mar-10-23 06:00PM	Schnitzer Steel (SCHN) Gains As Market Dips: What You Should Know (Zacks)
Feb-28-23 06:00PM	Schnitzer Steel (SCHN) Stock Moves -0.03%: What You Should Know (Zacks)
Feb-22-23 06:00PM	Schnitzer Steel (SCHN) Flat As Market Sinks: What You Should Know (Zacks)
Feb-14-23 06:00PM	Schnitzer Steel (SCHN) Gains As Market Dips: What You Should Know (Zacks)
Jan-30-23 02:38PM	7 of the Most Highly Rated ESG Companies to Invest in Now (InvestorPlace)
Jan-22-23 07:19AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Paying Out A Dividend Of $0.1875 (Simply Wall St.)
Jan-18-23 07:30AM	Schnitzer Steel Named Most Sustainable Company in the World by Corporate Knights (Business Wire)
01:03AM	Steel recycler beats wind firm to become world's most sustainable company (Reuters)
Jan-10-23 06:50AM	Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Q1 2023 Earnings Call Transcript (Insider Monkey) +9.26%
Jan-09-23 07:18AM	Schnitzer Steel Industries First Quarter 2023 Earnings: US$0.64 loss per share (vs US$1.64 profit in 1Q 2022) (Simply Wall St.)
Jan-08-23 07:17AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Paying Out A Dividend Of $0.1875 (Simply Wall St.)
Jan-05-23 08:00AM	Schnitzer Reports First Quarter Fiscal 2023 Financial Results (Business Wire)
Jan-03-23 09:40AM	Are Investors Undervaluing Schnitzer Steel Industries (SCHN) Right Now? (Zacks)
Jan-02-23 05:53AM	Schnitzer Steel Industries, Inc.'s (NASDAQ:SCHN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? (Simply Wall St.)
Dec-29-22 10:00AM	Analysts Estimate Schnitzer Steel (SCHN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Dec-26-22 09:40AM	Are Investors Undervaluing Aperam (APEMY) Right Now? (Zacks)
Dec-19-22 04:30PM	First Quarter Fiscal 2023 Preliminary Results and Announcement of Earnings Date (Business Wire)
Dec-16-22 07:29AM	Schnitzer Steel Industries' (NASDAQ:SCHN) investors will be pleased with their notable 60% return over the last three years (Simply Wall St.)
Dec-15-22 08:30AM	Schnitzer Steel Highlights Achievements on People, Planet, and Profit Goals in Its Fiscal Year 2022 Sustainability Report (Business Wire)
Dec-12-22 10:24AM	11 Best Steel Stocks To Buy Today (Insider Monkey)
Nov-25-22 01:42PM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Doing The Right Things To Multiply Its Share Price (Simply Wall St.)
Nov-16-22 10:25AM	11 Biggest Garbage Companies in the US (Insider Monkey)
Nov-14-22 08:30AM	Schnitzer Steel Industries, Inc. Appoints Gregory R. Friedman to its Board of Directors (Business Wire)
Nov-05-22 08:19AM	Here's What We Like About Schnitzer Steel Industries' (NASDAQ:SCHN) Upcoming Dividend (Simply Wall St.)
Oct-27-22 06:41AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Due To Pay A Dividend Of $0.1875 (Simply Wall St.) -5.89%
Oct-24-22 08:00AM	Schnitzer Reports Fourth Quarter and Fiscal 2022 Financial Results (Business Wire)
Oct-20-22 10:02AM	Analysts Estimate United States Steel (X) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-17-22 10:00AM	Analysts Estimate Schnitzer Steel (SCHN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-12-22 09:00AM	Schnitzer Steel Recertified as a Great Place to Work® (Business Wire)
08:26AM	The Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Analysts Have Been Trimming Their Sales Forecasts (Simply Wall St.)
Oct-07-22 07:58AM	Does This Valuation Of Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Imply Investors Are Overpaying? (Simply Wall St.)
Oct-04-22 06:30PM	Fourth Quarter and Fiscal 2022 Preliminary Results and Announcement of Earnings Date (Business Wire)
Aug-01-22 06:17PM	Schnitzer Steel appoints new CFO, shifting of financial team roles (American City Business Journals)
08:30AM	Schnitzer Steel Expands Role of Chief Strategy Officer and Appoints New Chief Financial Officer (Business Wire)
Jul-20-22 08:56AM	Could The Market Be Wrong About Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) Given Its Attractive Financial Prospects? (Simply Wall St.)
Jul-07-22 08:54AM	Implied Volatility Surging for Schnitzer Steel (SCHN) Stock Options (Zacks) +7.09%
Jul-02-22 08:18AM	Schnitzer Steel Industries (NASDAQ:SCHN) Is Due To Pay A Dividend Of US$0.19 (Simply Wall St.)
Jun-29-22 10:01AM	Schnitzer Steel shares advance on earnings (MarketWatch)
09:15AM	Schnitzer Steel (SCHN) Tops Q3 Earnings and Revenue Estimates (Zacks)
08:00AM	Schnitzer Reports Third Quarter Fiscal 2022 Financial Results (Business Wire)
Jun-24-22 09:33AM	Top 10 Stock Picks of Randall Smiths Alden Global (Insider Monkey)
Jun-14-22 03:32PM	Schnitzer Steel Industries' (NASDAQ:SCHN) five-year total shareholder returns outpace the underlying earnings growth (Simply Wall St.)

Radius Recycling, Inc. engages in the recycling of ferrous and nonferrous scrap metal and manufacture of finished steel products. The company was founded by Sam Schnitzer in 1906 and is headquartered in Portland, OR.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Souza Brian	SVP, Chief Ops Mgmt Officer	Nov 10 '23	Sale	23.49	4,500	105,705	18,767	Nov 14 07:13 PM
Heiskell Steven	SVP & President, Recycling P&S	Nov 07 '23	Sale	24.14	8,000	193,120	136,367	Nov 08 06:50 PM
Vaughn James Matthew	SVP, GC, CCO, Corp. Secretary	Nov 06 '23	Sale	24.83	571	14,178	6,608	Nov 07 01:42 PM
Gaggini Stefano R.	SVP, CFO	Nov 03 '23	Sale	24.86	7,269	180,707	63,295	Nov 07 01:35 PM
Heiskell Steven	SVP, Products & Services	May 05 '23	Sale	28.64	1,649	47,227	131,523	May 09 12:17 PM
Henderson Michael R	SVP, President, Operations	May 04 '23	Sale	27.44	1,691	46,401	132,769	May 08 10:28 AM
Gaggini Stefano R.	SVP, CFO	May 03 '23	Sale	28.43	1,026	29,164	62,374	May 05 12:15 PM
Schuessler Mark	VP and CAO	May 03 '23	Sale	28.51	157	4,476	7,730	May 05 12:16 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

CGEM

Cullinan Therapeutics Inc

RDUS

Radius Recycling Inc.

Upgrade your FINVIZ experience